Federated Hermes’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.9M Buy
70,885
+51,238
+261% +$2.82M 0.01% 788
2025
Q1
$1.39M Buy
19,647
+648
+3% +$45.8K ﹤0.01% 1024
2024
Q4
$1.25M Sell
18,999
-854
-4% -$56.1K ﹤0.01% 1047
2024
Q3
$1.4M Sell
19,853
-314
-2% -$22.1K ﹤0.01% 1029
2024
Q2
$1.66M Buy
+20,167
New +$1.66M ﹤0.01% 967
2023
Q4
Sell
-11,382
Closed -$1.01M 2056
2023
Q3
$1.01M Buy
+11,382
New +$1.01M ﹤0.01% 1107
2022
Q2
Sell
-3,998
Closed -$308K 2154
2022
Q1
$308K Sell
3,998
-10,019
-71% -$772K ﹤0.01% 1537
2021
Q4
$1.24M Buy
14,017
+8,943
+176% +$790K ﹤0.01% 1202
2021
Q3
$392K Sell
5,074
-116
-2% -$8.96K ﹤0.01% 1558
2021
Q2
$433K Buy
5,190
+670
+15% +$55.9K ﹤0.01% 1543
2021
Q1
$341K Sell
4,520
-527
-10% -$39.8K ﹤0.01% 1622
2020
Q4
$443K Buy
5,047
+1,324
+36% +$116K ﹤0.01% 1541
2020
Q3
$283K Sell
3,723
-49,967
-93% -$3.8M ﹤0.01% 1606
2020
Q2
$6.62M Buy
+53,690
New +$6.62M 0.02% 635
2019
Q1
Sell
-36
Closed -$3K 2149
2018
Q4
$3K Buy
+36
New +$3K ﹤0.01% 2035
2018
Q3
Sell
-14,200
Closed -$1.34M 2255
2018
Q2
$1.34M Hold
14,200
﹤0.01% 1178
2018
Q1
$1.15M Buy
14,200
+8,200
+137% +$665K ﹤0.01% 1180
2017
Q4
$535K Buy
+6,000
New +$535K ﹤0.01% 1365
2017
Q3
Sell
-20,264
Closed -$1.84M 2138
2017
Q2
$1.84M Buy
+20,264
New +$1.84M 0.01% 953
2017
Q1
Sell
-10,000
Closed -$828K 2117
2016
Q4
$828K Sell
10,000
-6,000
-38% -$497K ﹤0.01% 1177
2016
Q3
$1.48M Buy
16,000
+1,920
+14% +$178K ﹤0.01% 974
2016
Q2
$1.1M Buy
+14,080
New +$1.1M ﹤0.01% 1070
2015
Q2
Sell
-1,104
Closed -$138K 1961
2015
Q1
$138K Buy
+1,104
New +$138K ﹤0.01% 1559